Suchergebnisse - "Gans, Steven"

PubPharm (32)

1

Durvalumab in Combination With Olaparib Versus Durvalumab Alone as Maintenance Therapy in Metastatic NSCLC : The Phase 2 ORION Study

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2023

von Ahn, M. | Bondarenko, I. | Kalinka, E. | +14

2

Veliparib in Combination with Carboplatin and Etoposide in Patients with Treatment-Naïve Extensive-Stage Small Cell Lung Cancer : A Phase 2 Randomized Study

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2021

von Byers, L. | Bentsion, D. | Gans, S. | +15

3

Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI) : a randomised, controlled, phase 3b trial

enthalten in: The Lancet. Respiratory medicine | 2021

von Harrison, T. | Chanez, P. | Menzella, F. | +110

ErratumIn: Lancet Respir Med. 2021 Jan 25;:. - PMID 33508240

4

Exploratory analysis of front-line therapies in REVEL : a randomised phase 3 study of ramucirumab plus docetaxel versus docetaxel for the treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy

enthalten in: ESMO open | 2020

von Garon, E. | Scagliotti, G. | Gautschi, O. | +17

5

Exploratory analysis of front-line therapies in REVEL : a randomised phase 3 study of ramucirumab plus docetaxel versus docetaxel for the treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy

enthalten in: ESMO open | 2020

von Garon, E. | Scagliotti, G. | Gautschi, O. | +17

6

Successful treatment of azole-resistant invasive aspergillosis in a bottlenose dolphin with high-dose posaconazole

enthalten in: Medical mycology case reports | 2017

von Bunskoek, P. | Seyedmousavi, S. | Gans, S. | +5

7

Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib : phase III randomized LUX-Lung 5 trial

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2016

von Schuler, M. | Yang, J. | Park, K. | +118

CommentIn: Ann Oncol. 2016 Mar;27(3):367-8. - PMID 26924595

8

Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL) : a multicentre, double-blind, randomised phase 3 trial

enthalten in: Lancet (London, England) | 2014

von Garon, E. | Ciuleanu, T. | Arrieta, O. | +23

CommentIn: Lancet. 2014 Aug 23;384(9944):640-2. - PMID 24933331

9

Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial

enthalten in: The lancet | 2014

von Garon, E. | Ciuleanu, T. | Arrieta, O. | +23

10

Dasatinib-induced pulmonary arterial hypertension unresponsive to PDE-5 inhibition

enthalten in: The European respiratory journal | 2013

von Groeneveldt, J. | Gans, S. | Bogaard, H. | +1

CommentOn: Eur Respir J. 2013 Jan;41(1):85-95. - PMID 22523355